Control of viremia enables acquisition of resting memory B cells with age and normalization of activated B cell phenotypes in HIV-infected children

Journal of Immunology

Volumn 195, Issue 3, 2015, Pages 1082-1091

  Muema, Daniel M ^a   Macharia, Gladys N ^a   Hassan, Amin S ^a   Mwaringa, Shalton M ^a   Fegan, Greg W ^a,b   Berkley, James A ^a,b   Nduati, Eunice W ^a   Urban, Britta C ^a,c  

^a KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; B CELL ACTIVATING FACTOR; B CELL ACTIVATING FACTOR RECEPTOR; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; IMMUNOGLOBULIN G; TNFRSF13C PROTEIN, HUMAN; TNFSF13B PROTEIN, HUMAN;

AGE; ANTIGEN SPECIFICITY; ARTICLE; B LYMPHOCYTE ACTIVATION; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL COMPARTMENTALIZATION; CHILD; CONTROLLED STUDY; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; FLOW CYTOMETRY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMORAL IMMUNITY; INFECTION CONTROL; LYMPHOCYTE SUBPOPULATION; MAJOR CLINICAL STUDY; MALE; MEMORY CELL; PLASMABLAST; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; VIREMIA; VIRUS LOAD; ANTIBODY AFFINITY; B LYMPHOCYTE; BIOSYNTHESIS; BLOOD; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; INFANT; LYMPHOCYTE ACTIVATION; METABOLISM; NEWBORN; PRESCHOOL CHILD; TRANSMISSION; VERTICAL TRANSMISSION; VIROLOGY;

ANTIBODY AFFINITY; B-CELL ACTIVATING FACTOR; B-CELL ACTIVATION FACTOR RECEPTOR; B-LYMPHOCYTE SUBSETS; CHILD, PRESCHOOL; FEMALE; HIV ANTIBODIES; HIV INFECTIONS; HIV-1; HUMANS; IMMUNOGLOBULIN G; IMMUNOLOGIC MEMORY; INFANT; INFANT, NEWBORN; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; LYMPHOCYTE ACTIVATION; MALE; VIREMIA;

EID: 84937719532     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1500491     Document Type: Article

References (52)

1. Lane, H. C., H. Masur, L. C. Edgar, G. Whalen, A. H. Rook, and A. S. Fauci. 1983. Abnormalities of B-cell activation and immunoregulation in patients with the acquired immunodeficiency syndrome. N. Engl. J. Med. 309: 453-458.
2. Massabki, P. S., C. Accetturi, I. A. Nishie, N. P. da Silva, E. I. Sato, and L. E. Andrade. 1997. Clinical implications of autoantibodies in HIV infection. AIDS 11: 1845-1850.
3. Grogg, K. L., R. F. Miller, and A. Dogan. 2007. HIV infection and lymphoma. J. Clin. Pathol. 60: 1365-1372.
4. Racz, P., K. Tenner-Racz, F. van Vloten, H. Schmidt, M. Dietrich, J. C. Gluckman, N. L. Letvin, and G. Janossy. 1990. Lymphatic tissue changes in AIDS and other retrovirus infections: tools and insights. Lymphology 23: 85-91.
5. Moir, S., A. Malaspina, K. M. Ogwaro, E. T. Donoghue, C. W. Hallahan, L. A. Ehler, S. Liu, J. Adelsberger, R. Lapointe, P. Hwu, et al. 2001. HIV-1 induces phenotypic and functional perturbations of B cells in chronically infected individuals. Proc. Natl. Acad. Sci. USA 98: 10362-10367.
6. De Milito, A., A. Nilsson, K. Titanji, R. Thorstensson, E. Reizenstein, M. Narita, S. Grutzmeier, A. Sönnerborg, and F. Chiodi. 2004. Mechanisms of hypergammaglobulinemia and impaired antigen-specific humoral immunity in HIV-1 infection. Blood 103: 2180-2186.
7. Pensieroso, S., L. Galli, S. Nozza, N. Ruffin, A. Castagna, G. Tambussi, B. Hejdeman, D. Misciagna, A. Riva, M. Malnati, et al. 2013. B-cell subset alterations and correlated factors in HIV-1 infection. AIDS 27: 1209-1217.
8. Moir, S., C. M. Buckner, J. Ho, W. Wang, J. Chen, A. J. Waldner, J. G. Posada, L. Kardava, M. A. O'Shea, S. Kottilil, et al. 2010. B cells in early and chronic HIV infection: evidence for preservation of immune function associated with early initiation of antiretroviral therapy. Blood 116: 5571-5579.
9. Titanji, K., A. De Milito, A. Cagigi, R. Thorstensson, S. Grützmeier, A. Atlas, B. Hejdeman, F. P. Kroon, L. Lopalco, A. Nilsson, and F. Chiodi. 2006. Loss of memory B cells impairs maintenance of long-term serologic memory during HIV-1 infection. Blood 108: 1580-1587.
10. Rodriguez, B., H. Valdez, W. Freimuth, T. Butler, R. Asaad, and M. M. Lederman. 2003. Plasma levels of B-lymphocyte stimulator increase with HIV disease progression. AIDS 17: 1983-1985.
11. Moir, S., A. Malaspina, O. K. Pickeral, E. T. Donoghue, J. Vasquez, N. J. Miller, S. R. Krishnan, M. A. Planta, J. F. Turney, J. S. Justement, et al. 2004. Decreased survival of B cells of HIV-viremic patients mediated by altered expression of receptors of the TNF superfamily. J. Exp. Med. 200: 587-599.
12. WHO. 2010. Antiretroviral therapy for HIV infection in infants and children: towards universal access. Available at: http://www.who.int/hiv/pub/paediatric/ infants2010/en/. Accessed: October 31, 2014.
13. Rouet, F., M. L. Chaix, E. Nerrienet, N. Ngo-Giang-Huong, J. C. Plantier, M. Burgard, M. Peeters, F. Damond, D. K. Ekouevi, P. Msellati, et al. 2007. Impact of HIV-1 genetic diversity on plasma HIV-1 RNA quantification: usefulness of the Agence Nationale de Recherches sur le SIDA second-generation long terminal repeat-based real-time reverse transcriptase polymerase chain reaction test. J. Acquir. Immune Defic. Syndr. 45: 380-388.
14. Ndungu, F. M., A. Olotu, J. Mwacharo, M. Nyonda, J. Apfeld, L. K. Mramba, G. W. Fegan, P. Bejon, and K. Marsh. 2012. Memory B cells are a more reliable archive for historical antimalarial responses than plasma antibodies in no-longer exposed children. Proc. Natl. Acad. Sci. USA 109: 8247-8252.
15. Ibison, F., A. Olotu, D. M. Muema, J. Mwacharo, E. Ohuma, D. Kimani, K. Marsh, P. Bejon, and F. M. Ndungu. 2012. Lack of avidity maturation of merozoite antigen-specific antibodies with increasing exposure to Plasmodium falciparum amongst children and adults exposed to endemic malaria in Kenya. PLoS ONE 7: e52939.
16. Crotty, S., R. D. Aubert, J. Glidewell, and R. Ahmed. 2004. Tracking human antigen-specific memory B cells: a sensitive and generalized ELISPOT system. J. Immunol. Methods 286: 111-122.
17. Clutterbuck, E. A., S. Oh, M. Hamaluba, S. Westcar, P. C. Beverley, and A. J. Pollard. 2008. Serotype-specific and age-dependent generation of pneumococcal polysaccharide-specific memory B-cell and antibody responses to immunization with a pneumococcal conjugate vaccine. Clin. Vaccine Immunol. 15: 182-193.
18. Moir, S., A. Malaspina, J. Ho, W. Wang, A. C. Dipoto, M. A. O'Shea, G. Roby, J. M. Mican, S. Kottilil, T. W. Chun, et al. 2008. Normalization of B cell counts and subpopulations after antiretroviral therapy in chronic HIV disease. J. Infect. Dis. 197: 572-579.
19. Garett, J. M. 1999. PREDXCON: Stata module to calculate predicted means, medians, or proportions for a continuous X variable. Available at: https://ideas. repec.org/c/boc/bocode/s402602.html. Accessed August 10, 2014.
20. Malaspina, A., S. Moir, J. Ho, W. Wang, M. L. Howell, M. A. O'Shea, G. A. Roby, C. A. Rehm, J. M. Mican, T. W. Chun, and A. S. Fauci. 2006. Appearance of immature/transitional B cells in HIV-infected individuals with advanced disease: correlation with increased IL-7. Proc. Natl. Acad. Sci. USA 103: 2262-2267.
21. UNAIDS. 2013. Global report: UNAIDS report on the global AIDS epidemic. Available at: http://www.unaids.org/en/resources/documents/2013/20130923-UNAIDS-Global-Report-2013. Accessed: October 30, 2014.
22. Newell, M. L., H. Coovadia, M. Cortina-Borja, N. Rollins, P. Gaillard, and F. Dabis, Ghent International AIDS Society (IAS) Working Group on HIV Infection in Women and Children. 2004. Mortality of infected and uninfected infants born to HIV-infected mothers in Africa: a pooled analysis. Lancet 364: 1236-1243.
23. Moir, S., and A. S. Fauci. 2009. B cells in HIV infection and disease. Nat. Rev. Immunol. 9: 235-245.
24. De Milito, A., C. Mörch, A. Sönnerborg, and F. Chiodi. 2001. Loss of memory (CD27) B lymphocytes in HIV-1 infection. AIDS 15: 957-964.
25. Amu, S., N. Ruffin, B. Rethi, and F. Chiodi. 2013. Impairment of B-cell functions during HIV-1 infection. AIDS 27: 2323-2334.
26. Iwajomo, O. H., A. Finn, P. Moons, R. Nkhata, E. Sepako, A. D. Ogunniyi, N. A. Williams, and R. S. Heyderman. 2011. Deteriorating pneumococcalspecific B-cell memory in minimally symptomatic African children with HIV infection. J. Infect. Dis. 204: 534-543.
27. He, B., X. Qiao, P. J. Klasse, A. Chiu, A. Chadburn, D. M. Knowles, J. P. Moore, and A. Cerutti. 2006. HIV-1 envelope triggers polyclonal Ig class switch recombination through a CD40-independent mechanism involving BAFF and Ctype lectin receptors. J. Immunol. 176: 3931-3941.
28. Swingler, S., J. Zhou, C. Swingler, A. Dauphin, T. Greenough, P. Jolicoeur, and M. Stevenson. 2008. Evidence for a pathogenic determinant in HIV-1 Nef involved in B cell dysfunction in HIV/AIDS. Cell Host Microbe 4: 63-76.
29. Berberian, L., L. Goodglick, T. J. Kipps, and J. Braun. 1993. Immunoglobulin VH3 gene products: natural ligands for HIV gp120. Science 261: 1588-1591.
30. Martin, G., J. Roy, C. Barat, M. Ouellet, C. Gilbert, and M. J. Tremblay. 2007. Human immunodeficiency virus type 1-Associated CD40 ligand transactivates B lymphocytes and promotes infection of CD4+ T cells. J. Virol. 81: 5872-5881.
31. Hazenberg, M. D., S. A. Otto, B. H. van Benthem, M. T. Roos, R. A. Coutinho, J. M. Lange, D. Hamann, M. Prins, and F. Miedema. 2003. Persistent immune activation in HIV-1 infection is associated with progression to AIDS. AIDS 17: 1881-1888.
32. Pensieroso, S., A. Cagigi, P. Palma, A. Nilsson, C. Capponi, E. Freda, S. Bernardi, R. Thorstensson, F. Chiodi, and P. Rossi. 2009. Timing of HAART defines the integrity of memory B cells and the longevity of humoral responses in HIV-1 vertically-infected children. Proc. Natl. Acad. Sci. USA 106: 7939-7944.
33. Jacobsen, M. C., R. Thiébaut, C. Fisher, D. Sefe, M. Clapson, N. Klein, and H. E. Baxendale. 2008. Pediatric human immunodeficiency virus infection and circulating IgD+ memory B cells. J. Infect. Dis. 198: 481-485.
34. Kroon, F. P., G. F. Rimmelzwaan, M. T. Roos, A. D. Osterhaus, D. Hamann, F. Miedema, and J. T. van Dissel. 1998. Restored humoral immune response to influenza vaccination in HIV-infected adults treated with highly active antiretroviral therapy. AIDS 12: F217-F223.
35. Cagigi, A., F. Mowafi, L. V. Phuong Dang, K. Tenner-Racz, A. Atlas, S. Grutzmeier, P. Racz, F. Chiodi, and A. Nilsson. 2008. Altered expression of the receptor-ligand pair CXCR5/CXCL13 in B cells during chronic HIV-1 infection. Blood 112: 4401-4410.
36. Badr, G., G. Borhis, E. A. Lefevre, N. Chaoul, F. Deshayes, V. Dessirier, G. Lapree, A. Tsapis, and Y. Richard. 2008. BAFF enhances chemotaxis of primary human B cells: a particular synergy between BAFF and CXCL13 on memory B cells. Blood 111: 2744-2754.
37. Moss, W. J., S. Scott, N. Mugala, Z. Ndhlovu, J. A. Beeler, S. A. Audet, M. Ngala, S. Mwangala, C. Nkonga-Mwangilwa, J. J. Ryon, et al. 2007. Immunogenicity of standard-titer measles vaccine in HIV-1-infected and uninfected Zambian children: an observational study. J. Infect. Dis. 196: 347-355.
38. Nair, N., W. J. Moss, S. Scott, N. Mugala, Z. M. Ndhlovu, K. Lilo, J. J. Ryon, M. Monze, T. C. Quinn, S. Cousens, et al. 2009. HIV-1 infection in Zambian children impairs the development and avidity maturation of measles virusspecific immunoglobulin G after vaccination and infection. J. Infect. Dis. 200: 1031-1038.
39. Helfand, R. F., D. Witte, A. Fowlkes, P. Garcia, C. Yang, R. Fudzulani, L. Walls, S. Bae, P. Strebel, R. Broadhead, et al. 2008. Evaluation of the immune response to a 2-dose measles vaccination schedule administered at 6 and 9 months of age to HIV-infected and HIV-uninfected children in Malawi. J. Infect. Dis. 198: 1457-1465.
40. Gelinck, L. B., C. M. Jol-van der Zijde, A. M. Jansen-Hoogendijk, D. M. Brinkman, J. T. van Dissel, M. J. van Tol, and F. P. Kroon. 2009. Restoration of the antibody response upon rabies vaccination in HIV-infected patients treated with HAART. AIDS 23: 2451-2458.
41. Glennie, S. J., D. Banda, K. Gould, J. Hinds, A. Kamngona, D. D. Everett, N. A. Williams, and R. S. Heyderman. 2013. Defective pneumococcal-specific Th1 responses in HIV-infected adults precedes a loss of control of pneumococcal colonization. Clin. Infect. Dis. 56: 291-299.
42. Nduati, E., A. Gwela, H. Karanja, C. Mugyenyi, J. Langhorne, K. Marsh, and B. C. Urban. 2011. The plasma concentration of the B cell activating factor is increased in children with acute malaria. J. Infect. Dis. 204: 962-970.
43. Sellam, J., C. Miceli-Richard, J. E. Gottenberg, M. Ittah, F. Lavie, C. Lacabaratz, N. Gestermann, A. Proust, O. Lambotte, and X. Mariette. 2007. Decreased B cell activating factor receptor expression on peripheral lymphocytes associated with increased disease activity in primary Sjögren's syndrome and systemic lupus erythematosus. Ann. Rheum. Dis. 66: 790-797.
44. Vincent, F. B., E. F. Morand, P. Schneider, and F. Mackay. 2014. The BAFF/ APRIL system in SLE pathogenesis. Nat Rev Rheumatol 10: 365-373.
45. Darce, J. R., B. K. Arendt, X. Wu, and D. F. Jelinek. 2007. Regulated expression of BAFF-binding receptors during human B cell differentiation. J. Immunol. 179: 7276-7286.
46. Scholzen, A., A. C. Teirlinck, E. M. Bijker, M. Roestenberg, C. C. Hermsen, S. L. Hoffman, and R. W. Sauerwein. 2014. BAFF and BAFF receptor levels correlate with B cell subset activation and redistribution in controlled human malaria infection. J. Immunol. 192: 3719-3729.
47. Regidor, D. L., R. Detels, E. C. Breen, D. P. Widney, L. P. Jacobson, F. Palella, C. R. Rinaldo, J. H. Bream, and O. Martínez-Maza. 2011. Effect of highly active antiretroviral therapy on biomarkers of B-lymphocyte activation and inflammation. AIDS 25: 303-314.
48. Hansen, A., M. Odendahl, K. Reiter, A. M. Jacobi, E. Feist, J. Scholze, G. R. Burmester, P. E. Lipsky, and T. Dörner. 2002. Diminished peripheral blood memory B cells and accumulation of memory B cells in the salivary glands of patients with Sjögren's syndrome. Arthritis Rheum. 46: 2160-2171.
49. Avery, D. T., S. L. Kalled, J. I. Ellyard, C. Ambrose, S. A. Bixler, M. Thien, R. Brink, F. Mackay, P. D. Hodgkin, and S. G. Tangye. 2003. BAFF selectively enhances the survival of plasmablasts generated from human memory B cells. J. Clin. Invest. 112: 286-297.
50. Mandl, J. N., A. P. Barry, T. H. Vanderford, N. Kozyr, R. Chavan, S. Klucking, F. J. Barrat, R. L. Coffman, S. I. Staprans, and M. B. Feinberg. 2008. Divergent TLR7 and TLR9 signaling and type I interferon production distinguish pathogenic and nonpathogenic AIDS virus infections. Nat. Med. 14: 1077-1087.
51. Deeks, S. G., C. M. Kitchen, L. Liu, H. Guo, R. Gascon, A. B. Narváez, P. Hunt, J. N. Martin, J. O. Kahn, J. Levy, et al. 2004. Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load. Blood 104: 942-947.
52. WHO. 2013. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for public health approach. Available at: http://www.who.int/hiv/pub/guidelines/arv2013/en/ Accessed: October 31, 2014.